Advanced search
Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 33, 2003 - Issue 5
Submit an article Journal homepage
95
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Pharmacokinetics and disposition of a novel NMDA glycine site antagonist (UK-240,455) in rats, dogs and man

R. Webster Department of Drug Metabolism, Pfizer Global Research and Development, Sandwich CT13 9NJ, UK
,
S. Cole Department of Drug Metabolism, Pfizer Global Research and Development, Sandwich CT13 9NJ, UK
,
J. Gedge Department of Drug Metabolism, Pfizer Global Research and Development, Sandwich CT13 9NJ, UK
,
S. Roffey Department of Drug Metabolism, Pfizer Global Research and Development, Sandwich CT13 9NJ, UK
,
D. Walker Department of Drug Metabolism, Pfizer Global Research and Development, Sandwich CT13 9NJ, UK
&
W. Wild Department of Drug Metabolism, Pfizer Global Research and Development, Sandwich CT13 9NJ, UK
Pages 541-560 | Published online: 22 Sep 2008

References

  • BEAUMONT, K., HARPER, A., SMITH, D. and ABEL, S., 2000, Pharmacokinetics and metabolism of a sulphamide NK2 antagonist in rats, dogs and human. Xenobiotica, 30, 627–642.
  • BORDI, F., MUGNAINI, M., MANOLO, TERRON, A., BARNABY, R and REGGIANI, A., 2000, GV150526: a neuroprotective agent. CNS Drug Reviews, 6, 135–152.
  • BOXENBAUM, H., 1982, Interspecies scaling, allometry, physiological time, and the ground plan or pharmacokinetics. Journal of Pharmacokinetics and Biopharmaceutics, 10, 201–227.
  • CAO, X. and PHILLis, J., 1994, a-Phenyl-tetra-butyl-nitrone reduces cortical infarct and edema in rats subjected to focal ischemia. Brain Research, 644, 267–272.
  • DAVIES, B and MORRIS, T., 1993, Physiological parameters in laboratory animals and humans. Pharmaceutical Research, 10, 1093–1095.
  • DE LANGE, E. C. M., DANHOF, M., DE BOER, A. G. and BREIMER, D. D., 1997, Methodological considerations of intracerebral microdialysis in the pharmacokinetic studies of drug transport across the blood—brain barrier. Brain Research Reviews, 25, 27–49.
  • GORBY, V., BOUCHARD, G., CARRUPT, P. A., TESTA, B and GIRAULT, H. H., 2000, Physicochemical characteristics of sildenafil: ionisation, lipophilicity behavior, and ionic-partition diagram studies by two-phase titration and electrochemistry. Helvetica Chimica Acta, 83, 1465–1474.
  • HAMMARLUND-UDENAES, M., 2000, The use of microdialysis in CNS drug delivery studies. Pharmacokinetic perspectives and results with analgesics and antiepileptics. Advances in Drug Delivery Reviews, 45, 283–294.
  • HANADA, K., FUJISAWA, R., KATAOKA, R., NAKAMURA, S. and OGATA, H., 2001, Sex-related differences in the renal disposition of the acid metabolite of clentiazem in rats. Xenobiotica, 31, 725–731.
  • HE, Y., MURBY, S., WARHURST, GIORD, L., WALKER, D., AYRTON, J., EASTMOND, R. and ROWLAND, M., 1998, Species differences in size discrimination in the paracellular pathway reflected by oral bioavailability of polyethylene glycol and D-peptides. Journal of Pharmaceutical Science, 87, 626–633.
  • IRVINE, J. D., TAKAHASHI, L., LOCKHART, K., CHEONG, J., TOLAN, J. W., SELICK, H. E. and GROVE, J. R., 1999, MDCK (Madin-Darby canine kidney) cells: a tool for membrane permeability screening. Journal of Pharmaceutical Sciences, 88, 28–33.
  • SCHULZ, J., MATTHEWS, R., JENKINS, B. G., BRAR, P. and BEAL, M., 1995, Improved therapeutic window for the treatment of histotoxic hypoxia with a free radical spin trap. Journal of Cerebral Blood Flow and Metabolism, 15, 948–952.
  • SMITH, R., GRZELAK, M and COFFIN, V., 1994, Felbamate, a novel antiepileptic, does not affect cognition in rodents. Behavioural Pharmacology, 5, 365–368.
  • STOPHER, D and MCCLEAN, S., 1990, An improved method for the determination of distribution coefficients. Journal of Pharmacy and Pharmacology, 42, 144.
  • TANAKA, Y., DEGUCHI, Y., ISSHII, I. and TERAI, T., 1991, Sex differences in the excretion of zenarestat. Xenobiotica, 21, 1119–1125.
  • VAN DE WATERBEEMD, H. and SMITH, D. A., 2001, Relations of molecular properties with drug disposition: the case of gastrointestinal absorption and brain penetration. In B. Testa, H. van de Waterbeemd, G. Folkers and R. Guy (eds), Pharmacokinetic Optimization in Drug Research: Biological, Physiological and Computation Strategies (Zurich: Helvetica Chimica Acta), pp. 51-64.
  • WALKER, D. K., HALL, K. S., MUIRHEAD, G. J., PAGE, M. J., SMITH, D. A. and WILD, W., 1999 Pharmacokinetics of a thromboxane receptor antagonist, UK-147,535 in rat, rabbit, dog and man. British Journal of Clinical Pharmacology, 48, 885P.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.